Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325884 · ClinicalTrials.gov registry record
Long-term Outcomes of Patients After Coronary Bifurcation Stenting
A clinical trial, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- 160
- Enrollment target
NCT00325884: Completed study, sponsored by VA Boston Healthcare System.
NCT00325884 is a clinical trial that has completed, run by VA Boston Healthcare System. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00325884 has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long-term clinical outcomes after stenting bifurcation coronary artery lesions, and to determine whether simple or more complex techniques are associated with a better clinical outcome. We will also assess the risk factors associated with poorer clinical outcomes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2001-08 |
| Est. Completion | 2005-08 |
What the finished NCT00325884 record still lists
NCT00325884 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00325884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00325884 about?
NCT00325884 is a clinical study titled "Long-term Outcomes of Patients After Coronary Bifurcation Stenting". The purpose of this study is to assess the long-term clinical outcomes after stenting bifurcation coronary artery lesions, and to determine whether simple or more complex techniques are associated with a better clinical outcome. We will also assess the risk factors associated with poorer clinical ou...
What is the current status of trial NCT00325884?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2001-08. Estimated completion is 2005-08.
Who is sponsoring clinical trial NCT00325884?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia